Sunday 2 November 2025
Home      All news      Contact us      RSS     
Hongkong - 5 month ago

HKUMed leads global drug development using new ‘dual immunotherapy’ in liver-cancer patients, improving survival be receives international approvals

HKUMed leads global drug development using new ‘dual immunotherapy’ in liver-cancer patients, improving survival be receives international approvals


Latest News
Hashtags:   

HKUMed

 | 

leads

 | 

global

 | 

development

 | 

using

 | 

immunotherapy

 | 

liver

 | 

cancer

 | 

patients

 | 

improving

 | 

survival

 | 

receives

 | 

international

 | 

approvals

 | 

Sources